A Novel Colon Wall Flattening Model for Computed Tomographic Colonography: Method and Validation.

Comput Methods Biomech Biomed Eng Imaging Vis

Faculty of Dept. of Radiology, Stony Brook University, New York, USA.

Published: January 2014

Computed tomographic colonography (CTC) has been developed for screening of colon cancer. Flattening the three-dimensional (3D) colon wall into two-dimensional (2D) image is believed to (1) provide supplementary information to the endoscopic views and further (2) facilitate colon registration, taniae coli (TC) detection, and haustral fold segmentation. Though the previously-used conformal mapping-based flattening methods can preserve the angular geometry, they have the limitations in providing accurate information of the 3D inner colon wall due to the lack of undulating topography. In this paper, we present a novel colon-wall flattening method using a strategy of 2.5D approach. Coupling with the conformal flattening model, the presented new approach builds an elevation distance map to depict the neighborhood characteristics of the inner colon wall. We validated the new method via two CTC applications: TC detection and haustral fold segmentation. Experimental results demonstrated the effectiveness of our strategy for CTC studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310567PMC
http://dx.doi.org/10.1007/978-3-319-03590-1_1DOI Listing

Publication Analysis

Top Keywords

colon wall
16
flattening model
8
computed tomographic
8
tomographic colonography
8
detection haustral
8
haustral fold
8
fold segmentation
8
inner colon
8
flattening
5
colon
5

Similar Publications

Background: Cytomegalovirus (CMV) infection is common in the digestive and central nervous systems and can infect the entire digestive tract from the mouth to the rectum. In immunocompromised patients, CMV infection is prone to develop into CMV disease, especially in Acquired Immune Deficiency Syndrome (AIDS) patients. Severe cases may accelerate the progression of AIDS patients and form systemic CMV infection.

View Article and Find Full Text PDF

Ulcerative colitis is a chronic relapsing-remitting and potentially progressive form of inflammatory bowel disease in which there is extensive inflammation and mucosal damage in the colon and rectum as a result of an abnormal immune response. MV130 is a mucosal-trained immunity-based vaccine used to prevent respiratory tract infections in various clinical settings. Additionally, MV130 may induce innate immune cells that acquire anti-inflammatory properties and promote tolerance, which could have important implications for chronic inflammatory diseases such as ulcerative colitis.

View Article and Find Full Text PDF

Yeast fermentation products (YFPs) are known to contain bioactive compounds, such as nutritional metabolites and cell wall polysaccharides (specifically glucan and mannan), which have been demonstrated to exert positive effects on the growth performance and immunity of livestock and poultry. However, the impact of YFPs on intestinal inflammation and microflora composition in pigs infected with typhimurium remains unclear. To investigate this, a total of 18 weaned pigs were divided into three treatment groups: a non-challenged control group (Con), a group challenged with typhimurium (ST), and a group challenged with typhimurium and supplemented with 0.

View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) is a globally prevalent malignancy, primarily affecting the colon and rectum, characterized by uncontrolled cellular changes in the intestinal wall lining. Recent evidence underlines the significant role of the CXCL12/CXCR4 axis in the development of CRC, suggesting that inhibiting this pathway could be a promising therapeutic approach. This study focuses on investigating the potential of N, N''-thiocarbonylbis (N'-(3,4-dimethyl phenyl)-2,2,2-trifluoroacetimidamide) (A1), a novel fluorinated CXCR4 inhibitor, through a comprehensive analysis encompassing in silico, in vitro, and in vivo studies.

View Article and Find Full Text PDF

Introduction: Gastroenterocolitis is one of the adverse events related to immune checkpoint inhibitors. However, inflammation of the intestinal lesion used for urinary diversion is not well known as an adverse event related to their use.

Case Presentation: A patient with metastatic bladder cancer was administered pembrolizumab as second-line treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!